 Metoclopramide
"Metoclopramide" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
A dopamine D2 antagonist that is used as an antiemetic.
| Descriptor ID |
D008787
|
| MeSH Number(s) |
D02.065.277.573 D02.241.223.100.050.500.647 D02.241.223.100.100.510 D02.241.223.100.200.750 D02.241.223.100.300.350.625 D02.241.511.390.350.625 D02.455.426.559.389.127.020.937.647 D02.455.426.559.389.127.085.510 D02.455.426.559.389.127.250.750 D02.455.426.559.389.127.281.350.625 D02.455.426.559.389.657.654.638.625
|
| Concept/Terms |
Metoclopramide- Metoclopramide
- 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide
- Metaclopramide
Metoclopramide Hydrochloride- Metoclopramide Hydrochloride
- Hydrochloride, Metoclopramide
- Metoclopramide Monohydrochloride
- Monohydrochloride, Metoclopramide
- Metoclopramide Monohydrochloride, Monohydrate
|
Below are MeSH descriptors whose meaning is more general than "Metoclopramide".
Below are MeSH descriptors whose meaning is more specific than "Metoclopramide".
This graph shows the total number of publications written about "Metoclopramide" by people in this website by year, and whether "Metoclopramide" was a major or minor topic of these publications.
To see the data from this visualization as text, click here.
| Year | Major Topic | Minor Topic | Total |
|---|
| 1997 | 1 | 0 | 1 | | 1998 | 1 | 0 | 1 | | 2000 | 1 | 0 | 1 | | 2001 | 1 | 0 | 1 | | 2008 | 1 | 1 | 2 | | 2009 | 1 | 1 | 2 | | 2010 | 0 | 1 | 1 | | 2012 | 0 | 1 | 1 | | 2013 | 0 | 1 | 1 | | 2017 | 0 | 1 | 1 | | 2019 | 1 | 0 | 1 | | 2020 | 0 | 1 | 1 |
To return to the timeline, click here.
Below are the most recent publications written about "Metoclopramide" by people in Profiles.
-
Petri M, Singh I, Baker C, Underkofler C, Rasouli N. Diabetic gastroparesis: An overview of pathogenesis, clinical presentation and novel therapies, with a focus on ghrelin receptor agonists. J Diabetes Complications. 2021 02; 35(2):107733.
-
Bugaev N, Bhattacharya B, Chiu WC, Como JJ, Cripps MW, Ferrada P, Gelbard RB, Gondek S, Kasotakis G, Kim D, Mentzer C, Robinson BRH, Salcedo ES, Yeh DD. Promotility agents for the treatment of ileus in adult surgical patients: A practice management guideline from the Eastern Association for the Surgery of Trauma. J Trauma Acute Care Surg. 2019 10; 87(4):922-934.
-
Wei Y, La L, Wang L, Batey R, Wang C, Li Y. Paeoniflorin and liquiritin, two major constituents in Chinese herbal formulas used to treat hyperprolactinemia-associated disorders, inhibits prolactin secretion in prolactinoma cells by different mechanisms. J Ethnopharmacol. 2017 May 23; 204:36-44.
-
Holubkov R, Casper TC, Dean JM, Anand KJ, Zimmerman J, Meert KL, Newth CJ, Berger J, Harrison R, Willson DF, Nicholson C. The role of the Data and Safety Monitoring Board in a clinical trial: the CRISIS study. Pediatr Crit Care Med. 2013 May; 14(4):374-83.
-
Carcillo JA, Dean JM, Holubkov R, Berger J, Meert KL, Anand KJ, Zimmerman J, Newth CJ, Harrison R, Burr J, Willson DF, Nicholson C. The randomized comparative pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. Pediatr Crit Care Med. 2012 Mar; 13(2):165-73.
-
Sheinberg R, Gao WD, Wand G, Abraham S, Schulick R, Roy R, Mitter N. Case 1--2012. A perfect storm: fatality resulting from metoclopramide unmasking a pheochromocytoma and its management. J Cardiothorac Vasc Anesth. 2012 Feb; 26(1):161-5.
-
Ogungbenro K, Vasist L, Maclaren R, Dukes G, Young M, Aarons L. A semi-mechanistic gastric emptying model for the population pharmacokinetic analysis of orally administered acetaminophen in critically ill patients. Pharm Res. 2011 Feb; 28(2):394-404.
-
Maclaren R. Unanswered questions of "ProCon"etic therapy. JPEN J Parenter Enteral Nutr. 2009 Nov-Dec; 33(6):724-5.
-
Carcillo J, Holubkov R, Dean JM, Berger J, Meert KL, Anand KJ, Zimmerman J, Newth CJ, Harrison R, Willson DF, Nicholson C. Rationale and design of the pediatric critical illness stress-induced immune suppression (CRISIS) prevention trial. JPEN J Parenter Enteral Nutr. 2009 Jul-Aug; 33(4):368-74.
-
MacLaren R, Kiser TH, Fish DN, Wischmeyer PE. Erythromycin vs metoclopramide for facilitating gastric emptying and tolerance to intragastric nutrition in critically ill patients. JPEN J Parenter Enteral Nutr. 2008 Jul-Aug; 32(4):412-9.
|
People  People who have written about this concept. _
Similar Concepts
People who have written about this concept.
_
Top Journals
Top journals in which articles about this concept have been published.
|